Kurse werden geladen...
Prognose
Das durchschnittliche Kursziel der Analysten beträgt 11,78€(−1,01%). Der Median liegt bei 11,78€(−1,01%).
Kaufen | 3 |
Halten | 4 |
Verkaufen | 0 |
Scoring-Modelle
Dividenden-Strategie | 7 / 15 |
HGI-Strategie | 2 / 18 |
Levermann-Strategie | 1 / 13 |
News
4 Monthly Passive Income Stocks Yielding 8% to 12% Are Amazing Summer Bargains
Many investors seek solid passive income from quality dividend stocks.» Mehr auf 247wallst.com
Stellus Capital Investment Corporation (SCM) Q1 2025 Earnings Call Transcript
Stellus Capital Investment Corporation (NYSE:SCM ) Q1 2025 - Earnings Conference Call May 13, 2025 10:00 AM ET Company Participants Robert Ladd - Chief Executive Officer Todd Huskinson - Chief Financial Officer Conference Call Participants Eric Zwick - Lucid Capital Markets Christopher Nolan - Ladenburg Thalmann Robert Dodd - Raymond James Operator Good morning, ladies and gentlemen, and thank you for standing by. At this time, I would like to welcome everyone to Stellus Capital Investment Corporation's Conference Call to report financial results for its first fiscal quarter ended March 31, 2025.» Mehr auf seekingalpha.com
Hospital Information Systems Market Analysis Report 2025: Focus on EHR, CDSS, Specialty, Diagnostic, Pharmacy, Quality, SCM, PHM, RCM, Data Analytics, Telehealth - Global Forecast to 2030
The global hospital information systems market is set to soar to USD 116.75 billion by 2030, growing at a CAGR of 10.6% from 2024, boosted by government incentives and regulatory mandates like HIPAA and GDPR. Key driver segments include telehealth, driven by the need to curb infections and manage chronic diseases remotely. North America and Asia-Pacific lead regional growth, with APAC's surge fueled by robust healthcare IT adoption and government initiatives. The US faces rising healthcare costs prompting a shift to telehealth, while market leaders like Epic Systems and GE HealthCare push innovation in HIS. The global hospital information systems market is set to soar to USD 116.75 billion by 2030, growing at a CAGR of 10.6% from 2024, boosted by government incentives and regulatory mandates like HIPAA and GDPR. Key driver segments include telehealth, driven by the need to curb infections and manage chronic diseases remotely. North America and Asia-Pacific lead regional growth, with APAC's surge fueled by robust healthcare IT adoption and government initiatives. The US faces rising healthcare costs prompting a shift to telehealth, while market leaders like Epic Systems and GE HealthCare push innovation in HIS.» Mehr auf globenewswire.com
Historische Dividenden
Alle Dividenden KennzahlenUnternehmenszahlen
(EUR) | März 2025 | |
---|---|---|
Umsatz | 23,06 Bio | 443.548.263,14% |
Bruttoeinkommen | 0,00 | 100,00% |
Nettoeinkommen | 0,00 | 100,00% |
EBITDA | 0,00 | - |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 340,38 Mio€ |
Anzahl Aktien | 28,42 Mio |
52 Wochen-Hoch/Tief | 13,84€ - 9,95€ |
Dividendenrendite | 12,44% |
Dividenden TTM | 1,48€ |
Nächste Dividende | 0,12€ |
Beta | 0,87 |
KGV (PE Ratio) | 11,37 |
KGWV (PEG Ratio) | −1,03 |
KBV (PB Ratio) | 0,00 |
KUV (PS Ratio) | 0,00 |
Unternehmensprofil
Stellus Capital Investment Corporation ist eine Unternehmensentwicklungsgesellschaft, die sich auf Investitionen in private mittelständische Unternehmen spezialisiert hat. Die Investitionen erfolgen über First-Lien-, Second-Lien-, Unitranche- und Mezzanine-Finanzierungen, häufig mit einer entsprechenden Eigenkapitalbeteiligung. Der Fonds investiert vorzugsweise in den USA und Kanada. Der Fonds strebt Investitionen in Unternehmen mit einem EBITDA zwischen 5 und 50 Mio. USD an.
Name | Stellus Capital |
CEO | Robert Thomsen Ladd |
Sitz | Houston, tx USA |
Website | |
Industrie | Kapitalmärkte |
Börsengang | |
Mitarbeiter | 0 |
Ticker Symbole
Börse | Symbol |
---|---|
NYSE | SCM |
Frankfurt | GO0.F |
Düsseldorf | GO0.DU |
München | GO0.MU |
Assets entdecken
Shareholder von Stellus Capital investieren auch in folgende Assets